MorphoSys AG Statistics

Total Valuation

MorphoSys AG has a market cap or net worth of $2.82 billion. The enterprise value is $4.04 billion.

Market Cap	2.82B
Enterprise Value	4.04B

Important Dates

The next estimated earnings date is Wednesday, August 7, 2024, after market close.

Earnings Date	Aug 7, 2024
Ex-Dividend Date	n/a

Share Statistics

MorphoSys AG has 150.65 million shares outstanding.

Shares Outstanding	150.65M
Owned by Insiders (%)	n/a
Owned by Institutions (%)	7.44%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	322.58
PS Ratio	10.64
Forward PS	14.37
PB Ratio	52.72
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	15.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.08, with a Debt / Equity ratio of 36.87.

Current Ratio	3.08
Quick Ratio	2.71
Debt / Equity	36.87
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.34

Financial Efficiency

Return on equity (ROE) is -183.80% and return on invested capital (ROIC) is -13.59%.

Return on Equity (ROE)	-183.80%
Return on Assets (ROA)	-8.60%
Return on Capital (ROIC)	-13.59%
Revenue Per Employee	$505,255
Profits Per Employee	-$402,320
Employee Count	524
Asset Turnover	0.11
Inventory Turnover	1.28

Taxes

Income Tax	-1.29M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +120.14% in the last 52 weeks. The beta is 0.67, so MorphoSys AG's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	+120.14%
50-Day Moving Average	18.38
200-Day Moving Average	13.81
Relative Strength Index (RSI)	54.57
Average Volume (20 Days)	39,416

Short Selling Information

Short Interest	262,051
Short Previous Month	292,866
Short % of Shares Out	0.09%
Short % of Float	n/a
Short Ratio (days to cover)	3.61

Income Statement

In the last 12 months, MorphoSys AG had revenue of $264.75 million and -$210.82 million in losses. Loss per share was -$1.51.

Revenue	264.75M
Gross Profit	195.93M
Operating Income	-274.94M
Pretax Income	-207.91M
Net Income	-210.82M
EBITDA	-41.83M
EBIT	-53.30M
Loss Per Share	-$1.51

Full Income Statement

Balance Sheet

The company has $743.49 million in cash and $1.97 billion in debt, giving a net cash position of -$1.23 billion or -$8.14 per share.

Cash & Cash Equivalents	743.49M
Total Debt	1.97B
Net Cash	-1.23B
Net Cash Per Share	-$8.14
Equity (Book Value)	53.41M
Book Value Per Share	0.35
Working Capital	598.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$322.16 million and capital expenditures -$380,556, giving a free cash flow of -$322.54 million.

Operating Cash Flow	-322.16M
Capital Expenditures	-380,556
Free Cash Flow	-322.54M
FCF Per Share	-$2.35

Full Cash Flow Statement

Margins

Gross margin is 74.00%, with operating and profit margins of -103.85% and -79.63%.

Gross Margin	74.00%
Operating Margin	-103.85%
Pretax Margin	-78.53%
Profit Margin	-79.63%
EBITDA Margin	-15.80%
EBIT Margin	-20.13%
FCF Margin	-121.82%

Dividends & Yields

MorphoSys AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.46%
Shareholder Yield	-0.46%
Earnings Yield	-7.49%
FCF Yield	-11.46%

Dividend Details

Analyst Forecast

The average price target for MorphoSys AG is $12.13, which is -35.10% lower than the current price. The consensus rating is "Hold".

Price Target	$12.13
Price Target Difference	-35.10%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	33.94%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MorphoSys AG has an Altman Z-Score of 0.45 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.45
Piotroski F-Score	2